Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Cancer Research|October 15, 1992
Antitumor activity of the type 1 plasminogen activator inhibitor and cytotoxic conjugate in vitroJ JankunCancer Biochemistry Biophysics|March 30, 2000
Molecular basis of specific inhibition of urokinase plasminogen activator by amilorideJ Jankun, E Skrzypczak-JankunCurrent Molecular Medicine|June 14, 2011
Val17Ile single nucleotide polymorphisms similarly as Ala15Thr could be related to the lower secretory dynamics of PAI-1 secretion: theoretical evidenceJ Jankun, E Skrzypczak-JankunInternational Journal of Molecular Medicine|September 20, 2001
Binding site of amiloride to urokinase plasminogen activator depends on speciesJ Jankun, E Skrzypczak-JankunIEEE Transactions on Visualization and Computer Graphics|November 4, 2006
Detection and visualization of defects in 3D unstructured models of nematic liquid crystalsKetan Mehta, T J Jankun-KellyIEEE Transactions on Visualization and Computer Graphics|November 4, 2006
Superellipsoid-based, real symmetric traceless tensor glyphs motivated by nematic liquid crystal alignment visualizationT J Jankun-Kelly, Ketan MehtaIEEE Transactions on Visualization and Computer Graphics|March 7, 2012
Toward Visualization for Games: Theory, Design Space, and PatternsBrian Bowman, Niklas Elmqvist, T J Jankun-KellyJournal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|December 22, 2004
Plasminogen activator inhibitor type-1 controls the process of the in vitro sprout formationJ Chorostowska-Wynimko, E Skrzypczak-Jankun, J JankunJournal of Cellular Biochemistry|October 1, 1993
Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancersJ Jankun, H W Merrick, P J GoldblattCurrent Medicinal Chemistry|September 25, 2012
Human lipoxygenase: developments in its structure, function, relevance to diseases and challenges in drug developmentE Skrzypczak-Jankun, J Jankun, A Al-SenaidyPageof 3